Elligo Health Research, a developer of a clinical research platform, agreed to acquire ClinEdge, a provider of clinical trial, patient recruitment and business development services. Financial terms were not disclosed. “The combination with ClinEdge is a transformational moment in Elligo’s evolution as a company. Building on our access to over 150m diverse patients with EHR data, ClinEdge provides additional global scale for our customers in the US and Europe to enable the rapid acceleration of clinical trials through healthcare supporting all trial designs — traditional, hybrid, and direct-to-patient. ClinEdge customers retain their existing services, while also gaining access to Elligo’s research technology, data analytics, and accelerated trials platform," John Potthoff, Elligo CEO.